We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

MGI Tech Co., Ltd.

MGI Tech Co., Ltd. produces sequencing instruments, reagents, equipment and related products to support life science ... read more Featured Products: More products

Download Mobile App





MGI Tech Launches New MGISP-Smart 8 Automated Sample Preparation System at MEDLAB Middle East

By LabMedica International staff writers
Posted on 24 Jan 2022
Print article
Image: MGISP-Smart 8 (Photo courtesy of MGI Tech Co. Ltd.)
Image: MGISP-Smart 8 (Photo courtesy of MGI Tech Co. Ltd.)

MGI Tech Co. Ltd. (Shenzhen, China) unveiled its new MGISP-Smart 8 automated sample preparation system at MEDLAB Middle East 2022 held at the Dubai World Trade Center.

The event marked the debut of the MGISP-Smart 8 in international markets outside of China, where it was launched in October 2021. MGISP-Smart 8 will now be available in markets outside of China in April 2022. Additionally, MGI Tech also showcased its DNBSEQ-G400 and DNBSEQ-G50 gene sequencing platforms, MGISTP-3000 automated sample transfer processing system, mobile platform for automated and integrated nucleic acid testing.

MGISP-Smart 8 is an independent 8-channel pipetting robot that achieves flexible and customizable lab automation with several innovations in the pipette and gripper functions, such as independent multi-channel dynamic positioning and dual-level liquid detection. Equipped with high-end core technologies, such as an independent 8-channel pipette, intelligent integrated gripper and triple slide track design, MGISP-Smart 8 meets a variety of different application needs, from sequencing library preparation to nucleic acid detection and sample preparation.

MGISP-Smart 8 automates the pipetting and gripper function, which are two core functions for laboratories. With its independent eight-channel pipette for cherry-picking, the system flexibly and efficiently controls pipetting for a variety of lab scenarios and tasks. The system's pipetting volume ranges from 1μL to 1000μL, and eight independent pipettes support dual-level liquid detection for capacitance and pressure. MGISP-Smart 8 is also capable of undertaking pipette functions for different volumes, different channels and unequal intervals - making it adaptable to microplates, reservoirs and tubes. Meanwhile, the high precision integrated rotatable gripper directly connects to the peripheral integration instrument and detects gripping status in real-time to ensure experiment stability.

Beyond the pipette and gripper functions, MGISP-Smart 8 is extremely user-friendly and flexible with exceptional attention to details. The main workstation's triple stacked sliding deck design is adaptable to different modules, allowing users to flexibly combine modules like building blocks and conveniently replace modules at any time for applications' protocols. With 36 independent sliding tracks on the deck, MGISP-Smart 8 supports up to 30 SBS-standard layouts and works with seven types of consumable carriers. All tracks and deck positions are equipped with a position-sensing function, as well as induction functions to avoid misplacement errors in carrier and consumable advancement. MGISP-Smart 8 also works with different types of functional modules and is compatible with third-party kits with flexible software. As a flexible automated pipetting system, MGISP-Smart 8 covers different application scenarios in genomics, cell biology, proteomics, drug development, microbial screening and more. By fully automating operations, laboratories can improve efficiency; reduce errors in complex, repetitive liquid handling protocols; and free out researchers from tedious sample preparation work so they can devote more time onto more valuable tasks.

"Since our inception, MGI has been committed to developing our automated sample preparation systems business. The MGISP-960 and MGISP-100 have helped simplify tedious sample preparation tasks and been well-received by the international medical and scientific community, while the MGISTP-7000 automated sample transfer processing system and MGISP-NE384 automated nucleic acid extractor have supported pandemic prevention efforts for a number of countries worldwide. With the new MGISP-Smart 8, we have once again made a major breakthrough in lab automation. MGISP-Smart 8 builds on our existing systems with greater flexibility, intelligence and customization – enabling us to provide comprehensive lab automatic workflow for more fields and applications," said Dr. Roy Tan, General Manager of MGI Asia Pacific.

Related Links:
MGI Tech Co. Ltd. 

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Gold Member
Chagas Disease Test
CHAGAS Cassette
New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
New
DVT/PE Test
VIDAS D-DIMER EXCLUSION II

Print article

Channels

Molecular Diagnostics

view channel
Image: Umbilical cord blood biomarkers may improve preterm infant care (Photo courtesy of Shutterstock)

Umbilical Cord Blood Test Could Identify Preterm Infants at Risk for Medical Complications

Advancements in medical technology and neonatology have significantly improved the care of prematurely born infants. However, these infants still face heightened risks for medical complications, such as... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Microbiology

view channel
Image: The Cytovale System isolates, images, and analyzes cells (Photo courtesy of Cytovale)

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.